Acro-dermato-ungual-lacrimal-tooth syndrome （ADULT syndrome, OMIM 103285） is a rarely seen ectodermal dysplasia disorder first described by Propping and Zerres in 1993. ADULT syndrome is known as an autosomal domina...Acro-dermato-ungual-lacrimal-tooth syndrome （ADULT syndrome, OMIM 103285） is a rarely seen ectodermal dysplasia disorder first described by Propping and Zerres in 1993. ADULT syndrome is known as an autosomal dominant disorder. Only a family constellation and four independent cases were reported worldwide up to now. Here, we report a case of ADULT syndrome, which is the first case reported from China.展开更多
局部皮肤外用制剂因其给药方式的特殊性,在进行生物等效性(bioequivalence,BE)研究时需根据药物本身的特点和作用部位采用不同的研究方法。目前应用较广泛的体内药动学(pharmacokinetics,PK)方法、体内药效学(pharmacodynamics,PD)方法...局部皮肤外用制剂因其给药方式的特殊性,在进行生物等效性(bioequivalence,BE)研究时需根据药物本身的特点和作用部位采用不同的研究方法。目前应用较广泛的体内药动学(pharmacokinetics,PK)方法、体内药效学(pharmacodynamics,PD)方法、临床终点法等均存在一定的局限性。本文重点介绍了皮肤药物代谢动力学(dermato-pharmacokinetic,DPK)的原理及方法,讨论应用经皮水分散失值(trans-epidermal water loss,TEWL)法及其优化方法在局部经皮给药制剂生物等效性/生物利用度评价中的优势及研究进展,探讨其成为生物等效性替代评估法的可能性。针对DPK方法的标准操作规程和方法学确证需得到进一步的发展,以促进稳健的经皮给药制剂生物等效性评价方法的开发。展开更多
基金This study was supported by a grant from Guangdong Natural Science Foundation in 2006(No.06022455).
文摘Acro-dermato-ungual-lacrimal-tooth syndrome （ADULT syndrome, OMIM 103285） is a rarely seen ectodermal dysplasia disorder first described by Propping and Zerres in 1993. ADULT syndrome is known as an autosomal dominant disorder. Only a family constellation and four independent cases were reported worldwide up to now. Here, we report a case of ADULT syndrome, which is the first case reported from China.
文摘局部皮肤外用制剂因其给药方式的特殊性,在进行生物等效性(bioequivalence,BE)研究时需根据药物本身的特点和作用部位采用不同的研究方法。目前应用较广泛的体内药动学(pharmacokinetics,PK)方法、体内药效学(pharmacodynamics,PD)方法、临床终点法等均存在一定的局限性。本文重点介绍了皮肤药物代谢动力学(dermato-pharmacokinetic,DPK)的原理及方法,讨论应用经皮水分散失值(trans-epidermal water loss,TEWL)法及其优化方法在局部经皮给药制剂生物等效性/生物利用度评价中的优势及研究进展,探讨其成为生物等效性替代评估法的可能性。针对DPK方法的标准操作规程和方法学确证需得到进一步的发展,以促进稳健的经皮给药制剂生物等效性评价方法的开发。
